Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy

References

• Banoglu E, King RS. 2002. Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate. Eur J Drug Metab Pharmacokinet. 27(2):135–140.
   PubMed Web of Science ®Google Scholar
• Bray F. 2014. Transitions in human development and the global cancer burden. World Cancer Rep. 34:23–44.
   Google Scholar
• Decker M, Arand M, Cronin A. 2009. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol. 83(4):297–318.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AO. 2014. The role of epoxide hydrolases in health and disease. Arch Toxicol. 88(11):2013–2032.
   PubMed Web of Science ®Google Scholar
• Garcia SL, Lauritsen J, Zhang Z, Bandak M, Dalgaard MD, Nielsen RL, Daugaard G, Gupta R. 2020. Prediction of nephrotoxicity associated with cisplatin-based chemotherapy in testicular cancer patients. JNCI Cancer Spectr. 4(3):pkaa032.
   PubMed Web of Science ®Google Scholar
• Gresner P, Gromadzinska J, Wasowicz W. 2007. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer. 57(1):1–25.
   PubMed Web of Science ®Google Scholar
• Iwata K, Watanabe H, Morisaki T, Matsuzaki T, Ohmura T, Hamada A, Saito H. 2007. Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure. Pharm Res. 24(4):662–671.
   PubMed Web of Science ®Google Scholar
• Justenhoven C. 2012. Polymorphisms of phase I and phase II enzymes and breast cancer risk. Front Genet. 3:258.
   PubMedGoogle Scholar
• Khrunin AV, Khokhrin DV, Moisseev AA, Gorbunova VA, Limborska SA. 2014. Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer. Pharmacogenomics. 15(3):329–337.
   PubMed Web of Science ®Google Scholar
• Khrunin A, Moisseev A, Gorbunova V, Limborska S. 2018. Ethnic differences in susceptibility to the effects of platinum-based chemotherapy. In: Ovarian Cancer-From Pathogenesis to Treatment. 309.
   Google Scholar
• Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K. 2008. Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case–control study of familial prostate cancer in a Japanese population. Int Urol Nephrol. 40(4):947–951.
   PubMed Web of Science ®Google Scholar
• Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, Olson JL, Kroetz DL. 2012. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κBsignaling. J Pharmacol Exp Ther. 341(3):725–734.
   PubMed Web of Science ®Google Scholar
• Lv H, Han T, Shi X, Yao Y, Yao Y, Qiu W, Yue L, Liang J. 2014. Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer. Med Oncol. 31(8):86.
   PubMed Web of Science ®Google Scholar
• Mahasneh A, Jubaili A, El Bateiha A, Al-Ghazo M, Matalka I, Malkawi M. 2012. Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer. Genet Mol Biol. 35(4):725–733.
   PubMed Web of Science ®Google Scholar
• Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. 2010. Brian reeves. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel)). 2(11):2490–2518.
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. 2008. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83(5):584–594.
   PubMed Web of Science ®Google Scholar
• Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. 2004. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab. 5(5):363–373.
   PubMed Web of Science ®Google Scholar
• Oh ET, Park HJ. 2015. Implications of NQO1 in cancer therapy. BMB Rep. 48(11):609–617.
   PubMed Web of Science ®Google Scholar
• Parrish AR, Chen G, Burghardt RC, Watanabe T, Morisseau C, Hammock BD. 2009. Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase. Cell Biol Toxicol. 25(3):217–225.
   PubMed Web of Science ®Google Scholar
• Qi L, Li Y, Qin Y, Shi G, Li T, Wang J, Chen L, Gu Y, Zhao W, Guo Z. 2016. An individualized signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy. Br J Cancer. 115(12):1513–1519.
   PubMed Web of Science ®Google Scholar
• Ragunathan N, Dairou J, Pluvinage B, Martins M, Petit E, Janel N, Dupret J-M, Rodrigues-Lima F. 2008. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition. Mol Pharmacol. 73(6):1761–1768.
   PubMed Web of Science ®Google Scholar
• Ross D, Siegel D. 2017. Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch. Front Physiol. 8:595.
   PubMed Web of Science ®Google Scholar
• Sheweita SA, Tilmisany AK. 2003. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab. 4(1):45–58.
   Google Scholar
• Shields PG. 1999. Molecular epidemiology of lung cancer. Ann. Oncol. 10:S7–S11.
   PubMedGoogle Scholar
• Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. CA Cancer J Clin. 62(1):10–29.
   PubMed Web of Science ®Google Scholar
• Talalay P, Dinkova-Kostova AT. 2004. Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods Enzymol. 382:355–364.
   PubMed Web of Science ®Google Scholar
• Tian F, Zhang Y, Ren Y, Shen L, Wu W, Zhou B. 2014. N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. Medical Oncol. 31(8):90.
   PubMed Web of Science ®Google Scholar
• Tiang JM, Butcher NJ, Minchin RF. 2015. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines. Cancer Med. 4(4):565–574.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021. GSTP1 Ile105Val polymorphism among North Indian lung cancer patients treated using monotherapy and poly-pharmacy. Hum Exp Toxicol. 40(12_suppl):S739–S752.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021a. Association of NAT-2 gene polymorphisms toward lung cancer susceptibility and prognosis in North Indian patients treated with platinum-based chemotherapy. Pharmacogenomics. 23(2):97–118.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021b. Genetic polymorphism of Arg213His variant in the SULT1A1 gene is associated with reduced susceptibility to lung cancer in North Indian population. Xenobiotica. 51(9):1071–1080.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021c. Association of NQO1Pro187Ser polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. Per Med. 18(4):333–346.
   PubMed Web of Science ®Google Scholar
• Walia HK, Singh N, Sharma S. 2021d. Genetic polymorphisms in the mEH gene in relation to tobacco smoking: role in lung cancer susceptibility and survival in north Indian patients with lung cancer undergoing platinum-based chemotherapy. Future Oncol. 17(35):4925–4946.
   PubMed Web of Science ®Google Scholar
• Yabuuchi N, Hou H, Gunda N, Narita Y, Jono H, Saito H. 2021. Suppressed hepatic production of indoxyl sulfate attenuates cisplatin-induced acute kidney injury in sulfotransferase 1a1-deficient mice. IJMS. 22(4):1764.
   Google Scholar
• Yu W, Lin Z, Qu B. 2015. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations. Cell Biochem Biophys. 71(2):813–820.
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu Y, Chen G, Guo Q, Zhang Z, Zhao L, Wei R, Yin X, Zhang Y, Wang B. 2019. Association between NAT2 polymorphisms and acute leukemia risk: a meta-analysis. Medicine. 98(12):e14942.
   PubMed Web of Science ®Google Scholar